A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2031

Conditions

Venous Malformation, Low FlowAnticoagulants

Interventions

DRUG

Apixaban (Eliquis)

5 mg twice daily

DRUG

Placebo

placebo twice daily

Trial Locations (1)

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER